scholarly journals Detection of Immunoglobulin G and A Antibodies to Rubella Virus in Urine and Antibody Responses to Vaccine-Induced Infection

1998 ◽  
Vol 5 (1) ◽  
pp. 24-27 ◽  
Author(s):  
Shigeo Takahashi ◽  
Fusaichi Machikawa ◽  
Atsunari Noda ◽  
Tetsuya Oda ◽  
Tetsuya Tachikawa
Keyword(s):  
Healthy Volunteers ◽  
Immunoglobulin G ◽  
Rubella Virus ◽  
Enzyme Linked Immunosorbent Assay ◽  
Serum Samples ◽  
Recent Infection ◽  
Serum Igg ◽  
Assay Methods ◽  
Rubella Vaccination ◽  
Serum Igg Levels

ABSTRACT Urine and serum samples from 89 healthy volunteers and three healthy individuals who underwent rubella vaccination were tested for immunoglobulin G (IgG), IgA, and IgM to rubella virus (RV) by enzyme-linked immunosorbent assay methods. Subjects with positive (n = 68) or negative (n = 21) results for serum IgG were exactly the same as those with the corresponding results for urinary IgG. Both urinary and serum IgG levels remained elevated from the 3rd or 4th week after vaccination until the end of the study. Both urinary IgA and serum IgM levels tended to increase rapidly between the 3rd and 5th week and then gradually decrease until the end of the study, but the levels of both remained positive except for one sample each at the end (26th week). On the other hand, the ratio of anti-RV IgA titer to anti-RV IgG titer in urine (urinary anti-RV IgA/IgG ratio) increased rapidly between the 3rd and 4th week after vaccination and then rapidly returned to the ratio levels of the subjects positive for serum IgG from among the healthy volunteers. In summary, detection of urinary anti-RV IgG should be useful for screening for previous RV infection, and measurement of urinary anti-RV IgA/IgG ratio might be useful for diagnosing recent infection.

scholarly journals Detection of Rubella Virus-Specific Immunoglobulin G in Saliva by an Amplification-Based Enzyme-Linked Immunosorbent Assay Using Monoclonal Antibody to Fluorescein Isothiocyanate

1999 ◽  
Vol 37 (2) ◽  
pp. 391-395 ◽  
Author(s):  
A. J. Vyse ◽  
D. W. G. Brown ◽  
B. J. Cohen ◽  
R. Samuel ◽  
D. J. Nokes
Keyword(s):  
Immunosorbent Assay ◽  
Immunoglobulin G ◽  
Rubella Virus ◽  
Rank Correlation ◽  
Fluorescein Isothiocyanate ◽  
Enzyme Linked Immunosorbent Assay ◽  
Serum Samples ◽  
Capture Elisa ◽  
Amplification System ◽  
Specific Igg

An immunoglobulin G (IgG)–capture enzyme-linked immunosorbent assay (ELISA) for rubella virus is described. The assay uses a fluorescein isothiocyanate (FITC)–anti-FITC amplification system. The detection limit of the ELISA was approximately 7 IU of rubella virus-specific IgG per ml of serum sample. For saliva samples the performances of the capture ELISA and previously described radioimmunoassay were assessed, and the results of those two assays were compared to the rubella virus-specific IgG result obtained by a commercial ELISA (Behring Enzygnost) with a panel of paired serum and saliva samples. This comparison showed that the capture ELISA with saliva was more sensitive than the radioimmunoassay and that the results correlated better with the serum IgG result than the results of the radioimmunoassay did, with an overall sensitivity of 82% and a rank correlation of 0.68, whereas the sensitivity and rank correlation for the radioimmunoassay were 74% and 0.45, respectively. For subjects of 10 years of age or younger, the ELISA with saliva had a sensitivity of 94% and a specificity of 100% compared to the results of the ELISA (Behring Enzygnost) for rubella virus-specific IgG with corresponding serum samples. The sensitivity was much lower for subjects ages 17 years or older. The assay may have wider epidemiological use with saliva specimens, particularly those from children.

scholarly journals Evaluation of Brix Refractometry to Estimate Immunoglobulin G Content in Buffalo Colostrum and Neonatal Calf Serum

Animals ◽  
2021 ◽  
Vol 11 (9) ◽  
pp. 2616
Author(s):  
Melania Giammarco ◽  
Matteo Chincarini ◽  
Isa Fusaro ◽  
Anna Chiara Manetta ◽  
Alberto Contri ◽  
...  
Keyword(s):  
Immunoglobulin G ◽  
Calf Serum ◽  
Management Program ◽  
Passive Immunity ◽  
Enzyme Linked Immunosorbent Assay ◽  
Buffalo Calves ◽  
Serum Samples ◽  
Cut Point ◽  
Serum Igg ◽  
The Mean

Brix refractometry has been widely demonstrated to be a useful tool for monitoring colostrum management program and passive immunity transfer (PIT) in Bovines, but its suitability has never been verified in Buffalo. Therefore, the objective of this study was to evaluate the utility of a simple and rapid tool such as a digital Brix refractometer to estimate colostrum quality and for evaluating the success of passive transfer of immunoglobulin G (IgG) in Buffalo calves. The optimal cut points levels for Brix Refractometry for distinguishing good- and poor-quality colostrum and for assessing the adequacy of passive immunity transfer in calves were determined. For this aim, 26 first-milking maternal colostrum (MC) were collected from first-calf heifers. Blood samples were obtained from their calves at birth (T0) and 72 hours after (T3). Colostrum and Serum IgG content were determined by indirect enzyme-linked immunosorbent assay (ELISA), whereas total protein (TP, g/dL) and percentage Brix (%Brix) by means of a digital Brix refractometer. The mean colostrum IgG was 64.9 ± 29.3 mg/mL. The mean serum %Brix at T3 was 9.6 ± 0.9 %. The mean serum IgG content at T3 was 11.1 ± 2.0 mg/mL. Pearson’s correlation coefficient (rp) was determined between Brix and ELISA measurements: colostrum %Brix showed a significant correlation with serum %Brix (rp = 0.82, p < 0.001); serum %Brix was highly correlated with serum TP (STP, g/dL) (rp = 0.98, p < 0.001) and serum IgG (mg/mL) (rp = 0.85, p < 0.001). A cut point of 18% Brix to estimate samples of MC ≥ 50 mg/mL from first-calf heifers was more appropriate for the buffalo. A cut point of 8.4% Brix resulted in the greatest percentage of calf serum samples being correctly classified. Based on our findings, a digital Brix refractometer could be a useful tool to monitor colostrum quality and to estimate PIT in Buffalo calves.

scholarly journals Use of Dense Granule Antigen GRA6 in an Immunoglobulin G Avidity Test To Exclude Acute Toxoplasma gondii Infection during Pregnancy

2010 ◽  
Vol 17 (9) ◽  
pp. 1349-1355 ◽  
Author(s):  
Hossein Elyasi ◽  
Jalal Babaie ◽  
Hélène Fricker-Hidalgo ◽  
Marie-Pierre Brenier-Pinchart ◽  
Mehrak Zare ◽  
...  
Keyword(s):  
Toxoplasma Gondii ◽  
Immunoglobulin G ◽  
Chronic Infection ◽  
Dense Granule ◽  
Enzyme Linked Immunosorbent Assay ◽  
High Avidity ◽  
Igg Antibodies ◽  
Serum Samples ◽  
Recent Infection ◽  
Igg Avidity

ABSTRACT The usefulness of a specific immunoglobulin G (IgG) avidity enzyme-linked immunosorbent assay (ELISA) based on recombinant GRA6 antigen for distinguishing between acute and chronic Toxoplasma infection was investigated. Two sets of serum samples obtained from pregnant women with acute, chronic, or no Toxoplasma infection collected in France and Iran were used. Among the French subjects, 19 of 20 (95%) women who experienced seroconversion during the past 4 months before sampling displayed low-avidity IgG antibodies against GRA6, while all 17 (100%) women with chronic infection had high-avidity antibodies. When the Euroimmun IgG avidity ELISA was used, 15 of 19 (78.9%) recently infected women had low-avidity antibodies, and 20 of 22 (90.9%) women with chronic infection displayed high-avidity antibodies. The results suggested better performance of the GRA6 avidity ELISA than the Euroimmun avidity ELISA for exclusion of a recent infection occurring less than 4 months previously. Similarly, all 35 Iranian women with acute Toxoplasma infection had low-avidity antibodies against GRA6, whereas all 34 women with chronic infection displayed IgG antibodies of high avidity, indicating the value of GRA6 avidity testing for ruling out a recent infection. Avidity tests based on lysed whole-cell Toxoplasma gondii antigen are currently used to exclude recently acquired infections; however, the use of recombinant antigen(s) might improve the diagnostic performance of avidity tests and facilitate the development of more standardized assays.

scholarly journals Analysis of Specific Immunoglobulin G Subclass Antibodies for Serological Diagnosis of Echinococcosis by a Standard Enzyme-Linked Immunosorbent Assay

1998 ◽  
Vol 5 (5) ◽  
pp. 613-616 ◽  
Author(s):  
Felix Grimm ◽  
Friedrich E. Maly ◽  
Jian Lü ◽  
Roberto Llano
Keyword(s):  
Healthy Volunteers ◽  
Immunosorbent Assay ◽  
Immunoglobulin G ◽  
Serological Diagnosis ◽  
Enzyme Linked Immunosorbent Assay ◽  
Parasitic Infections ◽  
Igg Subclass ◽  
Specific Antibodies ◽  
Specific Igg4 ◽  
Antibody Levels

ABSTRACT The potential roles of specific antibodies of the different immunoglobulin G (IgG) subclasses in the serological diagnosis of cystic echinococcosis (CE) and alveolar echinococcosis (AE) were investigated by an enzyme-linked immunosorbent assay based on hydatid fluid as antigen. Specific antibodies of subclass 1 were found to be of major importance. In sera collected at the time of diagnosis (i.e., before any therapeutic intervention was initiated) they could be demonstrated in 14 of 15 sera from patients with CE and in all 12 sera from patients with AE. The most discriminatory and the most specific antibodies found in this study belonged to IgG subclass 4. Only one false-positive reaction was observed with 253 sera from healthy volunteers, and no cross-reactions occurred in 80 sera from patients with different parasitic infections. Specific IgG4 antibodies could be demonstrated in 61.0 to 66.7% (CE) or 47.6 to 66.7% (AE) of the cases. Antibody levels of IgG subclass 2 were elevated only moderately, and subclass 3 antibodies were detected in a few cases only. In addition, nonspecific reactions in sera of healthy volunteers or patients with other parasitic infections could partially be attributed to antibodies of subclasses 2 and 3.

scholarly journals Development of a Rapid and Convenient Method for Determination of Rubella Virus-Specific Immunoglobulin G Avidity

2007 ◽  
Vol 14 (11) ◽  
pp. 1416-1419 ◽  
Author(s):  
Christelle Vauloup-Fellous ◽  
Jessica Ursulet-Diser ◽  
Liliane Grangeot-Keros
Keyword(s):  
Immunoglobulin G ◽  
Rubella Virus ◽  
Primary Infection ◽  
Virus Infections ◽  
Serum Samples ◽  
Igg Avidity ◽  
Specific Immunoglobulin ◽  
Specific Igg ◽  
Semiautomated Method

ABSTRACT We describe here a rapid and semiautomated method for the determination of rubella virus immunoglobulin G (IgG) avidity with the VIDAS instrument. A total of 153 serum samples from persons with naturally acquired rubella virus infections (n = 98), from vaccinated persons (n = 44), and from patients with autoantibodies (n = 11) were included in this study. The rubella virus-specific IgG avidity assay we developed for the VIDAS instrument was evaluated by comparison with an in-house method. Results obtained with the VIDAS instrument allow considering this method valuable to help confirm or exclude acute primary infection or recent vaccination.

The Pharmacokinetics of Etanercept in Healthy Volunteers

2000 ◽  
Vol 34 (2) ◽  
pp. 161-164 ◽  
Author(s):  
Joan M Korth-Bradley ◽  
Abbe Sue Rubin ◽  
Roberta K Hanna ◽  
Donna K Simcoe ◽  
Mary E Lebsack
Keyword(s):  
Healthy Volunteers ◽  
Subcutaneous Injection ◽  
Peak Concentration ◽  
Subcutaneous Administration ◽  
Enzyme Linked Immunosorbent Assay ◽  
Pharmacokinetic Parameters ◽  
Time Data ◽  
Serum Samples ◽  
Drug Concentrations ◽  
Apparent Clearance

OBJECTIVE: To describe the pharmacokinetics of etanercept when administered by subcutaneous injection in single doses to healthy volunteers. METHODS: Twenty-six healthy volunteers between 19 and 50 years of age received single doses of etanercept 25 mg by subcutaneous injection into the abdomen. Serial serum samples were collected for 21 days. An enzyme-linked immunosorbent assay with a quantitation limit of 0.3 ng/mL was used to measure the drug concentrations. RESULTS: Etanercept was well tolerated by healthy volunteers. A one-compartment model was found to best describe the concentration–time data and was used to determine the pharmacokinetic parameters. Etanercept is slowly absorbed from the site of injection with a time of peak concentration (± SD) of 51 ± 14 hours; peak concentration was 1.46 ± 0.72 mg/L. The AUC was 235 ± 98 mg•h/L, apparent clearance was 132 ± 85 mL/h, apparent volume of distribution was 12 ± 6 L, and the half-life was 68 ± 19 hours. CONCLUSIONS: Etanercept was slowly absorbed and slowly eliminated after subcutaneous administration. Dosing at the recommended rate of 25 mg twice weekly would be expected to result in concentrations of approximately 3 mg/L. Intersubject variability for apparent clearance in healthy volunteers was 64%.

scholarly journals Standardized Method of MeasuringAcanthamoeba Antibodies in Sera from Healthy Human Subjects

2001 ◽  
Vol 8 (4) ◽  
pp. 724-730 ◽  
Author(s):  
Cynthia L. Chappell ◽  
John A. Wright ◽  
Michael Coletta ◽  
Anthony L. Newsome
Keyword(s):  
Human Subjects ◽  
Enzyme Linked Immunosorbent Assay ◽  
Serum Samples ◽  
Healthy Human ◽  
Serological Studies ◽  
Life Threatening ◽  
Assay Methods ◽  
Asymptomatic Infections ◽  
Acanthamoeba Culbertsoni ◽  
Positive Results

ABSTRACT Acanthamoeba species can cause serious, debilitating, and sometimes life-threatening infections. Three groups have been identified using morphological and immunological comparisons. Previous serological studies have utilized a variety of antigen preparations and assay methods and reported disparate (3 to 100%) results. This study was designed to (i) optimize an enzyme-linked immunosorbent assay for detecting serum antibodies to each of the Acanthamoebaserogroups and (ii) test 55 healthy individuals for specific immunoglobulin G reactivity. The highest signal-to-background ratio was found when 3,000 fixed, intact trophozoites per well were used with a 1:10 serum dilution. Sera yielding optical densities of <0.25 against all three Acanthamoeba serogroups were used to define the cutoff for positive results. The highest background reactivity with these sera was seen with Acanthamoeba polyphaga (serogroup 2), followed by Acanthamoeba culbertsoni (serogroup 3) andAcanthamoeba astronyxis (serogroup 1). Of 55 subjects tested, the highest number of positive results was seen with A. polyphaga (81.8%), followed by A. astronyxis(52.8%) and A. culbertsoni (40%). Seven serum samples (12.7%) were negative for all three Acanthamoebaserogroups, 16 (29.1%) were positive for one serogroup only, 16 were positive for two serogroups, and 16 reacted to all three serogroups. Further analysis showed no significant associations between serogroup reactivity and age or gender. However, some ethnic differences were noted, especially with A. polyphaga antigens. In that case, serum samples from Hispanic subjects were 14.5 times less likely to be positive (P = 0.0025) and had lower mean absorbance values (P = 0.047) than those from Caucasian subjects. Overall, these data suggest that Acanthamoeba colonization or infection is more common than previously thought. Mild or asymptomatic infections may contribute to the observed serum reactivities.

scholarly journals Immunoglobulin G, A and M Light Chain Ratio in Children

1992 ◽  
Vol 29 (3) ◽  
pp. 271-274 ◽  
Author(s):  
Á Haraldsson ◽  
C M R Weemaes ◽  
M J H Kock-Jansen ◽  
P B J M v Eck-Arts ◽  
T de Boo ◽  
...  
Keyword(s):  
Immunosorbent Assay ◽  
Light Chain ◽  
Immunoglobulin G ◽  
Age Groups ◽  
Enzyme Linked Immunosorbent Assay ◽  
Serum Samples ◽  
Λ Light Chain

Values for the κ/λ light chain ratio in immunoglobulins G, A and M and the total κ/λ ratio, measured by enzyme linked immunosorbent assay, were evaluated in serum samples from different age groups (114 children, aged from 1 month to 15 years, and 20 adults). The IgG κ/λ ratio decreased in the first 6 months and subsequently increased slowly during childhood towards the adult value of 2·0. The IgM κ/λ ratio increased at a greater rate than IgG κ/λ ratio in the first years of life and thereafter rose slightly throughout childhood to reach an adult value of 1·7. A decreasing IgA κ/λ ratio was found from 1 month of age onwards to an adult value of 1·1. The pattern of total κ/λ ratio was similar to the IgG κ/λ ratio with an adult value of 2·0.

scholarly journals Seroepidemiology of dengue and chikungunya fever in patients with rash and fever in Iran, 2017

2020 ◽  
Vol 148 ◽  
Author(s):  
Forough Tavakoli ◽  
Farhad Rezaei ◽  
Nazanin Zahra Shafiei-Jandaghi ◽  
Azadeh Shadab ◽  
Talat Mokhtari-Azad
Keyword(s):  
Statistical Analysis ◽  
Dengue Fever ◽  
Viral Infections ◽  
Denv Infection ◽  
Enzyme Linked Immunosorbent Assay ◽  
Epidemic Outbreak ◽  
Medical Sciences ◽  
Serum Samples ◽  
Seropositivity Rate ◽  
Rubella Vaccination

Abstract After the mass campaign of Measles and Rubella vaccination in 2003 in Iran, the cases of measles and rubella infection decreased but still, the cases of rash and fever were reported. It is worth noting that some other viral infections show signs similar to measles and rubella such as some arboviruses. Considering the epidemic outbreak of arbovirus infections in countries neighbouring Iran, we performed this study to estimate the possibility of chikungunya and dengue fever among measles and rubella IgM negative patients presenting with rash and fever from December 2016 to November 2017 in the National Measles Laboratory at Tehran University of Medical Sciences. Serum samples were selected at random from patients from eight provinces. The presence of DENV IgM and CHIKV IgM was examined by enzyme-linked immunosorbent assay. Of the 1306 sera tested, 210 were CHIKV seropositive and 82 were dengue seropositive. Statistical analysis demonstrated a significant increase in the CHIKV IgM antibody seropositivity rate in Kerman (OR = 2.07, 95% CI: 1.10–3.92; P = 0.024) and Fars (OR = 1.77, 95% CI: 1.06–2.93; P = 0.027). The DENV and CHIKV seropositivity rate in summer is higher than in other seasons (P < 0.01). Our seropositive samples suggest possible CHIKV and DENV infection in Iran. It is likely that these viruses are circulating in Iran and there is a need to study vector carriage of these two viruses.

scholarly journals Immunoglobulin G response and performance in Holstein calves supplemented with garlic powder and probiotics

2020 ◽  
Vol 50 (2) ◽  
pp. 263-270 ◽  
Author(s):  
T.W. Kekana ◽  
V.F. Nherera-Chokuda ◽  
J.J. Baloyi ◽  
C.M. Muya
Keyword(s):  
Body Temperature ◽  
Growth Performance ◽  
Immunoglobulin G ◽  
Garlic Powder ◽  
Serum Igg ◽  
Holstein Calves ◽  
And Performance ◽  
Natural Herb ◽  
Serum Igg Levels ◽  
Faecal Score

The study evaluated the effects of garlic, probiotics, and in combination on levels of immunoglobulin G (IgG) and growth performance in new-born Holstein calves. Thirty-two Holstein calves were randomly allocated to treatments at four days old and were maintained on them until they were 42 days old. The treatments consisted of control (C), garlic powder at 5 g/calf/day (GA), probiotics at 4 g/calf/day (PB), and the combination of garlic and probiotics (GP). Bodyweight, body length and heart girth measurements were taken to determine growth and blood was drawn to determine glucose and IgG. Faecal score and body temperature were recorded daily. Calves in GA and GP had higher IgG levels than calves in C and PB (28.0 g/L and 27.5 g/L versus 23.5 g/L and 25.5 g/L, respectively). Calves in GP and PB groups had lower faecal scores than C and GA (2.1 and 2.1 versus 2.3 and 2.2, respectively). Supplementation of GA, PB, and in combination did not affect feed intake and growth performance negatively, but improved serum IgG levels. Higher serum IgG in GP may indicate an improved intake and utilisation of nutrients that are responsible for immunity modulation and regulation. Probiotics and their combinations with garlic have the potential to reduce the incidence of diarrhoea when fed to young calves. Keywords: dairy neonates, direct-fed microbes, natural herb

Sign in / Sign up

Export Citation Format

Share Document